Home › Funds › Affinity Asset Advisors, LLC › ELVN

Affinity Asset Advisors, LLC position in ELVN

ENLIVEN THERAPEUTICS INC · Health Care

Affinity Asset Advisors, LLC reported holding 500,000 shares of ELVN (ENLIVEN THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$25.4M, representing 1.22% of its reported portfolio and ranking #25 among its reported holdings. Affinity Asset Advisors, LLC has disclosed ELVN holdings in 4 of the last 5 reported quarters, going back to Q2 2025.

Latest position (Q2 2026)500.00K sh
Reported value held$25.38M
Portfolio Weight1.22%
First reportedQ2 2025
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Affinity Asset Advisors, LLC's ELVN position evolved

Affinity Asset Advisors, LLC first disclosed a stake in ELVN in Q2 2025 at 400,000 shares (US$8.0M). The position peaked in Q2 2026 at 500,000 shares, worth US$25.4M. Across 4 filings, Affinity Asset Advisors, LLC increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 500,000 shares valued at US$25.4M — a reduction of -86,904 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q2 2025 400.00K $8.02M New
Q3 2025 400.00K $8.19M Hold
Q1 2026 586.90K $23.01M New
Q2 2026 500.00K $25.38M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ELVN and 13F data

ELVN (ENLIVEN THERAPEUTICS INC) is a Health Care company. 67 other funds we track also report a position in ELVN — the largest reported positions include ORBIMED ADVISORS LLC (US$343.9M), Polar Capital Holdings Plc (US$326.4M), Vestal Point Capital, LP (US$203.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ELVN

All ELVN fund holders →

FAQ

How long has Affinity Asset Advisors, LLC held ELVN?

Affinity Asset Advisors, LLC has disclosed ELVN holdings in 4 of the last 5 reported quarters, going back to Q2 2025.

What is Affinity Asset Advisors, LLC's current position in ELVN?

As of Q2 2026, Affinity Asset Advisors, LLC holds 500.00K shares of ELVN (ENLIVEN THERAPEUTICS INC), valued at $25.38M, representing 1.22% of its reported portfolio and ranking #25.

Has Affinity Asset Advisors, LLC been buying or selling ELVN?

In the latest 13F filing (Q2 2026), Affinity Asset Advisors, LLC reduced its position in ELVN. The position peaked in Q2 2026 at 500.00K shares.

Which other funds hold ELVN?

Other major institutional holders of ELVN include ORBIMED ADVISORS LLC, Polar Capital Holdings Plc, Vestal Point Capital, LP, among 67 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.